T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Fair Isaac
FICO
$22.6B
| $269M | 0.03% |
670,688
+481,050
| +254% | +$190M |
|
402
Otis Worldwide
OTIS
$28.2B
| $268M | 0.03% |
3,798,975
-163,878
| -4% | -$12.1M |
|
403
Procore
PCOR
$8.81B
| $267M | 0.03% |
5,871,821
+892,716
| +18% | +$43.8M |
|
404
ESAB
ESAB
$5.35B
| $266M | 0.03% |
+6,073,363
| New | +$293M |
|
|
NEE.PRP
405
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $265M | 0.03% |
5,341,781
+319,714
| +6% | +$15.7M |
|
406
Southwest Gas
SWX
$6.68B
| $265M | 0.03% |
3,041,768
-499,684
| -14% | -$44.1M |
|
|
ATVI
407
DELISTED
Activision Blizzard
ATVI
| $264M | 0.03% |
3,395,461
+492,489
| +17% | +$38.3M |
|
408
Ralph Lauren
RL
$23.6B
| $261M | 0.03% |
2,913,333
+778,289
| +36% | +$78.5M |
|
409
Option Care Health
OPCH
$3.57B
| $261M | 0.03% |
9,389,438
-323,712
| -3% | -$9.21M |
|
410
Clear Secure
YOU
$4.75B
| $259M | 0.03% |
12,953,197
-4,043,769
| -24% | -$109M |
|
411
Incyte
INCY
$24.5B
| $259M | 0.03% |
3,406,182
-1,286,023
| -27% | -$97.7M |
|
412
Strategic Education
STRA
$1.81B
| $258M | 0.03% |
3,650,052
+163,841
| +5% | +$10.9M |
|
|
KRTX
413
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $256M | 0.03% |
2,024,839
-86,395
| -4% | -$9.93M |
|
414
Raymond James Financial
RJF
$34.9B
| $256M | 0.03% |
2,857,665
-34,154
| -1% | -$3.35M |
|
415
Selective Insurance
SIGI
$5.59B
| $253M | 0.03% |
2,913,413
-14,867
| -0.5% | -$1.21M |
|
416
Novanta
NOVT
$6.32B
| $253M | 0.03% |
2,087,442
+829
| +0% | +$104K |
|
417
Manhattan Associates
MANH
$11.2B
| $253M | 0.03% |
2,203,350
+1,048
| +0% | +$130K |
|
418
Wingstop
WING
$3.05B
| $251M | 0.03% |
3,362,008
+29,899
| +0.9% | +$2.6M |
|
419
Five Below
FIVE
$13.2B
| $251M | 0.03% |
2,215,792
+97,132
| +5% | +$14M |
|
420
Kohl's
KSS
$2.19B
| $250M | 0.03% |
7,005,791
+734,427
| +12% | +$36M |
|
421
Diamondback Energy
FANG
$56.2B
| $250M | 0.03% |
2,062,342
-34,117
| -2% | -$4.68M |
|
422
Deere & Co
DE
$167B
| $250M | 0.03% |
833,767
-22,040
| -3% | -$8.11M |
|
423
SouthState Bank Corp
SSB
$10.7B
| $249M | 0.03% |
3,233,076
-467,460
| -13% | -$36.4M |
|
424
Leidos
LDOS
$17.6B
| $249M | 0.03% |
2,476,392
-432,970
| -15% | -$44.9M |
|
425
SPX Corp
SPXC
$10.9B
| $249M | 0.03% |
4,714,463
+105,851
| +2% | +$5.11M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.